News - OICR

  • oicr.on.ca
  • Front page
  • News Feed

August 22, 2018

Heliotrope: Personalizing cancer treatment decisions

Justin Cook poses for a photo in his office

OICR-developed software tool, Heliotrope, gains attention from the private sector for its potential to analyze large amounts of genomic information and inform clinical decision making

Continue reading – Heliotrope: Personalizing cancer treatment decisions

Share on Facebook Share on Twitter Share on Linkedin

Tags: Adaptive Oncology, FACIT, Genomics, Heliotrope, Lincoln Stein, University Health Network, Ziliomics Inc.

Subscribe to our newsletter

Our newsletter is the best way to stay up to date with what's happening at the Institute.

Sign up now

News releases

  • OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects
    February 21, 2019

  • New potential treatment for leukemia discovered by OICR scientists draws major industry investment
    January 29, 2019

  • FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
    January 29, 2019

  • Researchers discover common markers of tumour hypoxia across 19 cancer types
    January 14, 2019

  • See all news releases

Media Contact

Christopher Needles
Senior Manager, Strategic Communications

christopher.needles@oicr.on.ca
Telephone: 416-673-8505

Tweets by @OICR_news

For more information on OICR's research, careers, events and education, visit our corporate website: OICR.ON.CA

© 2019 Ontario Institute for Cancer Research. All rights reserved.
Terms and Conditions | Privacy statement | Policies

Ontario Government

Funding for the Ontario Institute for Cancer Research is provided by the Government of Ontario